Otsuka brings new CT contrast agent to U.S.

AuntMinnie.com staff writers
Jul 4, 2016

Otsuka Pharmaceutical has launched its OralTag abdominal CT contrast agent in the U.S.

Developed by Otsuka subsidiary Interpharma Praha, OralTag is a dissolvable powder form of iohexol. The U.S. Food and Drug Administration (FDA) approved OralTag in March 2015 for use as a radiographic contrast agent for opacifying the gastrointestinal tract during CT scanning of the abdomen and pelvis.

Otsuka noted that OralTag is not indicated for diagnostic examination of the gastrointestinal tract and is contraindicated in patients with a known hypersensitivity to iodinated contrast agents, including iohexol.

OralTag will be marketed by imaging accessories firm Beekley Medical and commercially available from Beekley subsidiary WMB Enterprises.

Latest in CT
Lung Illustration Blue
Clinical practice LCS program finds more disease than NLST
April 24, 2024
Lung Cancer
Novel risk prediction model improves LCS uptake
April 23, 2024
You think ahead. We innovate ahead.
Sponsored
You think ahead. We innovate ahead.
April 2, 2024
Lung Cancer
Tailored lung cancer screening model helps determine nodule follow-up
April 17, 2024
Related Stories
2015 10 02 16 16 58 339 Lungs Smoke 200
CT
Annual CT follow-up is safe for nonsolid lung nodules
2016 06 28 15 03 23 358 2016 07 Sahani Multiple Followup 200
CT
CT technique tames Tower of Babel from different IR schemes
2014 02 18 12 29 39 212 Question Mark Blue 200
CT
What does the Joint Commission really want with CT?
You think ahead. We innovate ahead.
Sponsor Content
You think ahead. We innovate ahead.
More in CT
Clinical practice LCS program finds more disease than NLST
By Kate Madden Yee
Over a five-year period, a clinical practice lung cancer screening program at Duke University Medical Center in Durham, NC, found more disease than did the National Lung Screening Trial (NLST), researchers have reported.
April 24, 2024
Lung Illustration Blue
Novel risk prediction model improves LCS uptake
By Kate Madden Yee
A novel risk prediction model used in the Ontario Lung Cancer Screening Pilot increased the uptake of lung cancer screening among eligible Canadians, researchers have found.
April 23, 2024
Lung Cancer
Radiologist consultation improves patients' LCS attitudes
By Kate Madden Yee
Consulting with a radiologist boosts patients' attitudes toward lung cancer screening (LCS) and their interest in quitting smoking, researchers have reported.
April 18, 2024
Doctor Female Young Desk 400
Tailored lung cancer screening model helps determine nodule follow-up
By Kate Madden Yee
A personalized lung cancer screening model used with patients with pulmonary nodules identified on low-dose CT helps clinicians determine how to follow up better than rule-based protocols, researchers have found.
April 17, 2024
Lung Cancer
CT-based deep learning identifies patients at further lung cancer risk
By Kate Madden Yee
A CT-based deep learning model can identify individuals with clinical stage IA non-small cell lung cancer (NSCLC) at high risk of further disease, researchers have found.
April 16, 2024
Ai
CT-FFR reduces invasive procedures for coronary artery blockages
By Kate Madden Yee
CT fractional flow reserve (CT-FFR) imaging identifies patients with coronary artery blockage or narrowing who could benefit from revascularization -- and helps reduce the unnecessary use of invasive procedures, researchers have found.
April 11, 2024
Heart Pulmonary Trunk
Experts say consider BMI when imaging patients with chest pain
By Will Morton
A patient’s body mass index (BMI) has a significant effect on how much radiation exposure they receive from chest imaging in cases of suspected cardiac ischemia.
April 11, 2024
Heart Attack
AI model predicts invasiveness of lung cancer on CT scans
By Will Morton
Radiologists in Beijing, China, have developed a joint deep-learning and radiomics AI model that can flag how invasive tumors may be in patients with lung cancer.
April 9, 2024
Lung Ai
Is CTA overused in the emergency department?
By Amerigo Allegretto
CT angiography (CTA) may be overused in the emergency department, new research suggests.
April 1, 2024
Patient Elderly Confused Headache 400
Deep learning helps distinguish benign vertebral fractures on CT
By Kate Madden Yee
A deep-learning algorithm used with CT imaging can differentiate between benign and malignant vertebral fractures, researchers have found.
March 27, 2024
Overview of the automated deep learning-based pipeline. Multidetector CT images show the (A) original data, (B, C) vertebral segmentation, and (D-F) vertebral labeling during preprocessing. Images and caption courtesy of the RSNA.
The rise of theranostics: Part 1 -- Gaining momentum
By Liz Carey
FDA-approved radiopharmaceuticals have energized the field of theranostics. In part 1 of a series, experienced theranostics leaders offer implications of the latest clinical trials, how a theranostics clinic works, and advice for introducing theranostics.
March 26, 2024
Team members from the theranostics clinic under University of Texas Health Science Center at San Antonio's Department of Radiology show one aspect of a Pluvicto infusion treatment. The L block lead shield over the syringe helps protect certified nuclear medicine technologist James Johnson (left), and nuclear radiologist Penny Vroman, MD (right), from radiation emitted by the drug. (Photo courtesy of UT Health San Antonio Department of Radiology)
CT shows effects of sarcopenia on liver cancer survival
By Kate Madden Yee
CT has revealed that sarcopenia is a prognostic factor for poor overall survival after liver resection for cancer, researchers have reported.
March 22, 2024
Liver Cancer
Page 1 of 654
Next Page